Name :
MED15 antibody
Documents :
DataSheet Material Safety Data Sheets (MSDS)
Description :
MED15 Rabbit Polyclonal antibody. Positive WB detected in K-562 cells. Positive IP detected in K-562 cells. Positive IHC detected in human prostate cancer tissue. Positive IF detected in SH-SY5Y cells. Observed molecular weight by Western-blot: 105 kDa
Tested applications :
ELISA, WB, IHC, IP, IF
Species reactivity :
Human; other species not tested.
Alternative names :
ARC105 antibody; CAG7A antibody; CTG repeat protein 7a antibody; CTG7A antibody; DKFZp686A2214 antibody; DKFZp762B1216 antibody; FLJ42282 antibody; FLJ42935 antibody; MED15 antibody; mediator complex subunit 15 antibody; PCQAP antibody; TIG 1 antibody; TIG1 antibody; TNRC7 antibody; TPA inducible gene 1 protein antibody
Immunogen :
Isotype :
Rabbit IgG
Preparation :
This antibody was obtained by immunization of MED15 recombinant protein (Accession Number: BC017110). Purification method: Antigen affinity purified.
Clonality :
Polyclonal
Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
Storage instructions :
Store at -20℃. DO NOT ALIQUOT
Applications :
Recommended Dilution: WB: 1:500-1:5000IP: 1:200-1:2000IHC: 1:20-1:200IF: 1:20-1:200
Background :
MED15, also named as TIG1, CAG7A, CTG7A, PCQAP, TIG-1, TNRC7 and ARC105, is a subunit of the multiprotein complexes PC2 and ARC/DRIP and may function as a transcriptional coactivator in RNA polymerase II transcription. It contains stretches of trinucleotide repeats and is located in the chromosome 22 region which is deleted in DiGeorge syndrome.MED15 is recruited to promoters by direct interaction with gene-specific regulatory proteins. It is about 105kd in SDS-page.
References :
Shaikhibrahim Z, Menon R, Braun M. MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer. International journal of cancer. 135(1):19-26. 2014. Nakatsubo T, Nishitani S, Kikuchi Y. Human mediator subunit MED15 promotes transcriptional activation. Drug discoveries & therapeutics. 8(5):212-7. 2014. Shaikhibrahim Z, Offermann A, Halbach R. Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma. The American journal of pathology. 185(4):1114-22. 2015. Klümper N, Syring I, Offermann A. Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors. Diagnostic pathology. 10:165. 2015. Kumafuji M, Umemura H, Furumoto T, Fukasawa R, Tanaka A, Ohkuma Y. Mediator MED18 subunit plays a negative role in transcription via the CDK/cyclin module. Genes to cells : devoted to molecular & cellular mechanisms. 19(7):582-93. 2014. Wezensky SJ, Hanks TS, Wilkison MJ, Ammons MC, Siemsen DW, Gauss KA. Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex. Gene. 452(1):22-34. 2010. Tsutsui T, Fukasawa R, Tanaka A, Hirose Y, Okhuma Y. Identification of target genes for the CDK subunits of the Mediator complex. Genes to cells : devoted to molecular & cellular mechanisms. 16(12):1208-18. 2011. Tsutsui T, Fukasawa R, Shinmyouzu K. Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes. The Journal of biological chemistry. 288(29):20955-65. 2013.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXP3 Antibody (YA858) Technical Information
Tocilizumab Autophagy
PKC delta Antibody: PKC delta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC delta. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.